The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Distance to Diagnosing Provider as a Measure of Access for Patients With Melanoma
Open accessAbstract
OBJECTIVE: To examine the effect of travel distance and other sociodemographic factors on access to a diagnosing provider for patients with melanoma. DESIGN: Analysis was performed of all incident cases of melanoma in 2000 from 42 North Carolina counties. SETTING: Academic research. PARTICIPANTS: Patients and providers from 42 North Carolina counties were geocoded to street address. MAIN OUTCOME MEASURES: Associations between Breslow thickness and clinical and sociodemographic factors (age, sex, poverty rate, rurality, provider supply, and distance to diagnosing provider) were examined. RESULTS: Of 643 eligible cases, 4.4% were excluded because of missing data. The median Breslow thickness was 0.6 mm (range, 0.1-20.0 mm). The median distance to diagnosing provider was 8 miles (range, 0-386 miles). For each 1-mile increase in distance, Breslow thickness increased by 0.6% (P =.003). For each 1% increase in poverty rate, Breslow thickness increased by 1% (P =.04). Breslow thickness was 19% greater for patients aged 51 to 80 years than for those aged 0 to 50 years (P =.02) and was 109% greater for patients older than 80 years than for those aged 0 to 50 years (P < .001). Sex, rurality, and supply of dermatologists were not associated with Breslow thickness. CONCLUSIONS: For patients with melanoma, distance to the diagnosing provider is a meaningful measure of access that captures different information than community-level measures of rurality, provider supply, and socioeconomic status. Future work should be targeted at identifying factors that may affect distance to diagnosing provider and serve as barriers to melanoma care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, various authors have reported difficulties in obtaining an appointment with a dermatologist [12,14-17].”
From Use of Smartphones for Early Detection of Melanoma: Systematic Review (2018) · cites this paper as [16]
Citations
Cites
Balch, C. M., Soong, S., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M. M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,383
Krieger, N. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf068 · Cited by 1,185
Access to Health Care in America
Institute of Medicine (1993) · National Academies Press eBooks · doi:10.17226/2009 · Cited by 649
Athas, W. F., Adams-Cameron, M., Hunt, W., Amir-Fazli, A., & Key, C. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.269 · Cited by 442
Screening for Cutaneous Melanoma by Skin Self-Examination
Berwick, M., Begg, C. B., Fine, J. A., Roush, G. C., & Barnhill, R. L. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.1.17 · Cited by 430
Self-citationRace, socioeconomic status and stage at diagnosis for five common malignancies
Schwartz, K., Crossley‐May, H., Vigneau, F. D., Brown, K., & Banerjee, M. (2003) · Cancer Causes & Control · doi:10.1023/a:1026321923883 · Cited by 311
Correlation Between Prognostic Factors and Increasing Age in Melanoma
Chao, C., Martin, R. C. G., Ross, M. I., Reintgen, D. S., Edwards, M. J., Noyes, R. D., Hagendoorn, L. J., Stromberg, A. J., & McMasters, K. M. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.04.015 · Cited by 219
Lifetime Risk of Melanoma in CDKN2A Mutation Carriers in a Population-Based Sample
Begg, C. B., Orlow, I., Hummer, A., Armstrong, B. K., Kricker, A., Marrett, L. D., Millikan, R. C., Gruber, S. B., Anton‐Culver, H., Zanetti, R., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji312 · Cited by 214
Self-citationTransportation as a barrier to cancer treatment.
Guidry, J. J., Aday, L. A., Zhang, D., & Winn, R. (1997) · PubMed · Cited by 199
Comparing Alternative Methods of Measuring Geographic Access to Health Services
Fortney, J. C., ROST, K. M., & Warren, J. J. (2000) · Health Services and Outcomes Research Methodology · doi:10.1023/a:1012545106828 · Cited by 193
Is Patient Travel Distance Associated With Survival on Phase II Clinical Trials in Oncology?
Lamont, E. B., Hayreh, D., Pickett, K. E., Dignam, J. J., List, M. A., Stenson, K. M., Haraf, D. J., Brockstein, B., Sellergren, S. A., & Vokes, E. E. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg035 · Cited by 139
Age as a prognostic factor in the malignant melanoma population
Austin, P. F., Cruse, C. W., Lyman, G. H., Schroer, K. R., Glass, F., & Reintgen, D. S. (1994) · Annals of Surgical Oncology · doi:10.1007/bf02303614 · Cited by 126
Impact of deprivation and rural residence on treatment of colorectal and lung cancer
Campbell, N. C., Elliott, A. M., Sharp, L., Ritchie, L. D., Cassidy, J., & Little, J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600515 · Cited by 117
MacKie, R. M., & Hole, D. J. (1996) · BMJ · doi:10.1136/bmj.312.7039.1125 · Cited by 115
Socioeconomic status and breast carcinoma survival in four racial/ethnic groups
O’Malley, C. D., Le, G. M., Glaser, S. L., Shema, S. J., & West, D. W. (2003) · Cancer · doi:10.1002/cncr.11160 · Cited by 113
Re: Is Patient Travel Distance Associated With Survival on Phase II Clinical Trials in Oncology?
Munoz, A., & Samet, J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh065 · Cited by 112
Clinical and dermatoscopic criteria for the preoperative evaluation of cutaneous melanoma thickness
Argenziano, G., Fabbrocini, G., Carli, P., GIORGI, V. D., & Delfino, M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70528-1 · Cited by 111
Sensitivity in the clinical diagnosis of malignant melanoma
Wolf, I. H., Smolle, J., Soyer, H. P., & Kerl, H. (1998) · Melanoma Research · doi:10.1097/00008390-199810000-00007 · Cited by 101
Analyzing Geographic Patterns of Disease Incidence: Rates of Late-Stage Colorectal Cancer in Iowa
Rushton, G., Peleg, I., Banerjee, A., Smith, G., & West, M. (2004) · Journal of medical systems · doi:10.1023/b:joms.0000032841.39701.36 · Cited by 90
Roetzheim, R. G., Pal, N., Durme, D. J. V., Wathington, D., Ferrante, J. M., Gonzalez, E. C., & Krischer, J. P. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.106242 · Cited by 86
Cutaneous melanoma mortality among the socioeconomically disadvantaged in Massachusetts.
Geller, A. C., Miller, D. R., Lew, R. A., Clapp, R., Wenneker, M. B., & Koh, H. K. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.4.538 · Cited by 85
Socioeconomic effects on breast cancer survival: proportion attributable to stage and morphology
Kaffashian, F., Godward, S., Davies, T. W., Solomon, L., McCann, J., & Duffy, S. W. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601339 · Cited by 83
Malignant melanoma in the elderly.
Cohen, H. J., Cox, E., Mantón, K. G., & Woodbury, M. A. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.100 · Cited by 73
Demographic Predictors of Melanoma Stage at Diagnosis
Van Durme, D. J. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.7.606 · Cited by 60
Accuracy in clinically evaluating pigmented lesions.
Curley, R. K., Cook, M. G., Fallowfield, M. E., & Marsden, R. A. (1989) · BMJ · doi:10.1136/bmj.299.6690.16 · Cited by 58
Bono, A. V., Bartoli, C., Cascinelli, N., Lualdi, M., Maurichi, A., Moglia, D., Tragni, G., Tomatis, S., & Marchesini, R. (2002) · Dermatology · doi:10.1159/000066436 · Cited by 56
Prospective Study of the Accuracy of the Surgeon's Diagnosis in 2000 Excised Skin Tumors
Hallock, G. G., & Lutz, D. A. (1998) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-199804050-00014 · Cited by 54
Familial aggregation of melanoma risks in a large population-based sample of melanoma cases
Begg, C. B., Hummer, A., Mujumdar, U., Armstrong, B. K., Kricker, A., Marrett, L. D., Millikan, R. C., Gruber, S. B., Anton‐Culver, H., Klotz, J. B., et al. (2004) · Cancer Causes & Control · doi:10.1007/s10522-004-2474-2 · Cited by 54
Self-citationLenhard, R. E., Enterline, J. P., Crowley, J. J., & Ho, G. Y. F. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1640 · Cited by 48
Kreher, N. E., Hickner, J. M., Ruffin, M. T., & Lin, S. L. C. S. (1995) · PubMed · Cited by 36
Iredale, R., Jones, L., Gray, J. R., & Deaville, J. (2004) · Health & Place · doi:10.1016/j.healthplace.2004.06.005 · Cited by 32
Cancer of the corpus uteri in white and black women in Michigan, 1985-1994
Madison, T., Schottenfeld, D., & Baker, V. M. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981015)83:8 · Cited by 27
Effects of Physician Supply on Melanoma Incidence and Mortality in Florida
Durme, D. J. V., Ullman, R., Bell, C. M., & Roetzheim, R. G. (2003) · Southern Medical Journal · doi:10.1097/01.smj.0000053569.81565.19 · Cited by 23
Does palpability of primary cutaneous melanoma predict dermal invasion?
O’Donnell, B. F., Marsden, J. R., O'Donnell, C. A., Sanders, D. S. A., & Billingham, C. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)80063-6 · Cited by 19
Primary malignant brain tumor incidence and Medicaid enrollment
Sherwood, P. R., Stommel, M., Murman, D. L., Given, C. W., & Given, B. A. (2004) · Neurology · doi:10.1212/01.wnl.0000125195.26224.7c · Cited by 18
Self-reported cervical screening practices and beliefs of women from urban, rural and remote regions
Girgis, A. (1999) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443619965543 · Cited by 9
Flagged first, then by citations
Cited by
Sorted by citations
Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature
Ambroggi, M., Biasini, C., Giovane, C. D., Fornari, F., & Cavanna, L. (2015) · The Oncologist · doi:10.1634/theoncologist.2015-0110 · Cited by 551
Rural–Urban Differences in Cancer Incidence and Trends in the United States
Zahnd, W. E., James, A. S., Jenkins, W. D., Izadi, S. R., Fogleman, A. J., Steward, D. E., Colditz, G. A., & Brard, L. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0430 · Cited by 443
The US dermatology workforce: a specialty remains in shortage.
Kimball, A. B., & Resneck, J. S. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.06.037 · Cited by 257
Rural Residence and Cancer Outcomes in the United States: Issues and Challenges
Meilleur, A., Subramanian, S. V., Plascak, J. J., Fisher, J. L., Paskett, E. D., & Lamont, E. B. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0404 · Cited by 247
Comparison of Dermatologist Density Between Urban and Rural Counties in the United States
Feng, H., Berk-Krauss, J., Feng, P. W., & Stein, J. (2018) · JAMA Dermatology · doi:10.1001/jamadermatol.2018.3022 · Cited by 211
Metadata
- Authors
- Stitzenberg, K. B., Thomas, N. E., Dalton, K., Brier, S. E., Ollila, D. W., Berwick, M., Mattingly, D., & Millikan, R. C.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- University of New Mexico (US)
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2007-08-01
- Volume
- 143
- Issue
- 8
- Pages
- 991-8
- ISSN
- 0003-987X (ISSN-L)
- PMC
- PMC3629703
- OpenAlex
- W2054994397
- Cited by
- 119
- References
- 36
- Citations by year
- 2026: 12 · 2025: 7 · 2024: 10 · 2023: 9 · 2022: 10 · 2021: 13 · 2020: 8 · 2019: 7 · 2018: 8 · 2017: 5 · 2016: 5 · 2015: 2 · 2014: 4 · 2013: 1 · 2012: 4
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of Dermatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Agency for Healthcare Research and Quality (T32HS000032, T32-HS00032)
- National Cancer Institute (K07CA102096, R01CA112243, U01CA083180)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Health › Health disparities and outcomes
- Keywords
- melanoma, health care access, travel distance, Breslow thickness, sociodemographic factors, poverty, age, rurality, health disparities, North Carolina
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Health Services Accessibility, Humans, Male, Melanoma, Middle Aged, Neoplasm Staging, North Carolina, Retrospective Studies, Skin Neoplasms, Socioeconomic Factors, Incidence, Linear Models, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
